IVI’s MISSION is to advance the science and improve the practice of value assessment in healthcare.
IVI’s GOAL is to build a platform that facilitates robust and rigorous patient-centered value assessment of health technologies tailored to the needs and interests of individual decision makers.
The Value Debate
Scientific, technological, and clinical advances are driving a revolution in patient care – but spending on healthcare also continues to increase. Most observers agree that change is needed in order to link healthcare spending to value rather than volume, but determining how to make this link quickly leads to debate and disagreement. What defines value? Value to whom? And how do we measure it?
A New Approach
The Innovation and Value Initiative (IVI) was created to raise the level of discussion regarding value in healthcare and find common ground in the approach to measuring value. The U.S health system is diverse, complex, and ripe for innovation. IVI brings together healthcare leaders from academia, patient advocacy organizations, payers, life sciences companies, providers, delivery systems, and patient communities to advance approaches to value that fit the American context.
Patients are likely to continue to be asked to take more responsibility for their healthcare…it is time to shift the discussion toward helping patients understand what value actually means in choosing their health care and discharging their financial responsibilities.
Thank you for your comments! IVI has released all public feedback received during the open comment period for the IVI-NSCLC model - our open-source platform to assess therapy sequences for EGFR+ non-small cell lung cancer. [...]
In the wake of this year's ISPOR conference, IVI's Executive Director, Jennifer Bright, reflects on how to move value assessment from a static snapshot in time to an active learning approach. She discusses the following [...]
Heard at ISPOR: Wide Ranging Podcast with IVI on Advanced Value Assessment Methods and the QALY Controversy
The IVI team sat down with the Journal of Clinical Pathways while at ISPOR for an in-depth discussion about why advanced value assessment is needed and how it’s progressing. The team also discussed the QALY [...]
As part of the public input process, IVI submitted comments on the Institute for Clinical and Economic Review’s (ICER) 2020 Value Assessment Framework. In May, ICER invited public comments as part of their process to [...]